부산대학교 도서관

Stefańczyk SA; Kaiser X; Hagelstein I; Lutz MS; Holzmayer SJ; Zekri L; Märklin M; Jung S

ImmunoTargets and Therapy, Vol 15, Iss Issue 1, Pp 1-14 (2026)

Greiner, S. M.; Mauermann, J.; Lutz, M. S.; Hagelstein, I.; Hartkopf, A. D.; Zekri, L.; Jung, G.; Salih, H. R.; Märklin, M.

Journal of Translational Medicine. 23(1)

Jonas S. Heitmann; Claudia Tandler; Maddalena Marconato; Annika Nelde; Timorshah Habibzada; Susanne M. Rittig; Christian M. Tegeler; Yacine Maringer; Simon U. Jaeger; Monika Denk; Marion Richter; Melek T. Oezbek; Karl-Heinz Wiesmüller; Jens Bauer; Jonas Rieth; Marcel Wacker; Sarah M. Schroeder; Naomi Hoenisch Gravel; Jonas Scheid; Melanie Märklin; Annika Henrich; Boris Klimovich; Kim L. Clar; Martina Lutz; Samuel Holzmayer; Sebastian Hörber; Andreas Peter; Christoph Meisner; Imma Fischer; Markus W. Löffler; Caroline Anna Peuker; Stefan Habringer; Thorsten O. Goetze; Elke Jäger; Hans-Georg Rammensee; Helmut R. Salih; Juliane S. Walz

Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)

Ho, Jenny N.H.G. ; Schmidt, Dominik ; Lowinus, Theresa ; Ryoo, Jeongmin ; Dopfer, Elaine-Pashupati ; Gonzalo Núñez, Nicolás ; Costa-Pereira, Sara ; Toffalori, Cristina ; Punta, Marco ; Fetsch, Viktor ; Wertheimer, Tobias ; Rittmann, Marie-Claire ; Braun, Lukas M. ; Follo, Marie ; Briere, Christelle ; Vinnakota, Janaki Manoja ; Langenbach, Marlene ; Koppers, Felicitas ; Shoumariyeh, Khalid ; Engel, Helena ; Rückert, Tamina ; Märklin, Melanie ; Holzmayer, Samuel ; Illert, Anna L. ; Magon, Federica ; Andrieux, Geoffroy ; Duquesne, Sandra ; Pfeifer, Dietmar ; Staniek, Julian ; Rizzi, Marta ; Miething, Cornelius ; Köhler, Natalie ; Duyster, Justus ; Menssen, Hans D. ; Boerries, Melanie ; Buescher, Joerg M. ; Cabezas-Wallscheid, Nina ; Blazar, Bruce R. ; Apostolova, Petya ; Vago, Luca ; Pearce, Erika L. ; Becher, Burkhard ; Zeiser, Robert

In Blood 8 September 2022 140(10):1167-1181

Stefańczyk SA; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Kaiser X; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Hagelstein I; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Holzmayer S; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Zekri L; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Jung S; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Märklin M; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Seller, Anna; Tegeler, Christian M.; Mauermann, Jonas; Schreiber, Tatjana; Hagelstein, Ilona; Liebel, Kai; Koch, André; Heitmann, Jonas S.; Greiner, Sarah M.; Hayn, Clara; Dannehl, Dominik; Engler, Tobias; Hartkopf, Andreas D.; Hahn, Markus; Brucker, Sara Y.; Salih, Helmut R.; Märklin, Melanie

International Journal of Molecular Sciences. April, 2024, Vol. 25 Issue 7

Zwick M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Zinkel B; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Spohr C; Institute of Molecular Medicine and Cell Research (IMMZ), Zentrum für Biochemie und Molekulare Zellforschung (ZBMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Rückert T; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Halbach S; Institute of Molecular Medicine and Cell Research (IMMZ), Zentrum für Biochemie und Molekulare Zellforschung (ZBMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Shoumariyeh K; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Scheid J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department for Computer Science, Biomedical Data Science, University of Tübingen, Tübingen, Germany.; Baur AS; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.; Braun LM; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Angel M; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Institute of Molecular Medicine and Cell Research (IMMZ), Zentrum für Biochemie und Molekulare Zellforschung (ZBMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Michaeli E; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Todkar A; Renal Division, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Märklin M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Holzmayer SJ; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Dicks S; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Boerries M; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Duquesne S; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Schlaak AE; Department of Internal Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Otto-Mora P; Department of Internal Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Bengsch B; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Department of Internal Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; BIOSS Center for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Schiff M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Kissel S; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Selle M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Follo M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Altmann H; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Kunadt D; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Illert AL; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Klinikum Rechts der Isar, Faculty of Medicine, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Walz JS; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Walz G; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Renal Division, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; BIOSS Center for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Duyster J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Clinical Trials Unit, DKMS gGmbH, Dresden, Germany.; Brummer T; Institute of Molecular Medicine and Cell Research (IMMZ), Zentrum für Biochemie und Molekulare Zellforschung (ZBMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; BIOSS Center for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Zeiser R; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; BIOSS Center for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Köhler N; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Kaidun, Polina; Holzmayer, Samuel J.; Greiner, Sarah M.; Seller, Anna; Tegeler, Christian M.; Hagelstein, Ilona; Mauermann, Jonas; Engler, Tobias; Koch, André; Hartkopf, Andreas D.; Salih, Helmut R.; Märklin, Melanie

International Journal of Molecular Sciences. August, 2023, Vol. 24 Issue 17

Greiner, Sarah M.; Märklin, Melanie; Holzmayer, Samuel; Kaban, Kübra; Meyer, Sophie; Hinterleitner, Clemens; Tandler, Claudia; Hagelstein, Ilona; Jung, Gundram; Salih, Helmut R.; Heitmann, Jonas S.; Kauer, Joseph

Annals of Hematology. :1-8

Greiner, S. M.; Mauermann, J.; Lutz, M. S.; Hagelstein, I.; Hartkopf, A. D.; Zekri, L.; Jung, G.; Salih, H. R.; Märklin, M.

Annika Nelde; Heiko Schuster; Jonas S. Heitmann; Jens Bauer; Yacine Maringer; Melissa Zwick; Jens-Peter Volkmer; James Y. Chen; Anna M. Paczulla Stanger; Ariane Lehmann; Bismark Appiah; Melanie Märklin; Elke Rücker-Braun; Helmut R. Salih; Malte Roerden; Sarah M. Schroeder; Max-Felix Häring; Andreas Schlosser; Johannes Schetelig; Marc Schmitz; Melanie Boerries; Natalie Köhler; Claudia Lengerke; Ravindra Majeti; Irving L. Weissman; Hans-Georg Rammensee; Juliane S. Walz

Blood Cancer Discov

Norris, Lesley A.; Rabner, Jonathan C.; Marklin, Marika; Crane, Margaret E.; Renschler, Kathrin; Jenkins, Emma; Kemp, Joshua; Storch, Eric A.; Wood, Jeffrey J.; Kerns, Connor M.; Lewin, Adam B.; Small, Brent J.; Kendall, Philip C.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS; FEB 10 2025, 12p.

Juliane S. Walz; Hans-Georg Rammensee; Irving L. Weissman; Ravindra Majeti; Claudia Lengerke; Natalie Köhler; Melanie Boerries; Marc Schmitz; Johannes Schetelig; Andreas Schlosser; Max-Felix Häring; Sarah M. Schroeder; Malte Roerden; Helmut R. Salih; Elke Rücker-Braun; Melanie Märklin; Bismark Appiah; Ariane Lehmann; Anna M. Paczulla Stanger; James Y. Chen; Jens-Peter Volkmer; Melissa Zwick; Yacine Maringer; Jens Bauer; Jonas S. Heitmann; Heiko Schuster; Annika Nelde

Juliane S. Walz; Hans-Georg Rammensee; Irving L. Weissman; Ravindra Majeti; Claudia Lengerke; Natalie Köhler; Melanie Boerries; Marc Schmitz; Johannes Schetelig; Andreas Schlosser; Max-Felix Häring; Sarah M. Schroeder; Malte Roerden; Helmut R. Salih; Elke Rücker-Braun; Melanie Märklin; Bismark Appiah; Ariane Lehmann; Anna M. Paczulla Stanger; James Y. Chen; Jens-Peter Volkmer; Melissa Zwick; Yacine Maringer; Jens Bauer; Jonas S. Heitmann; Heiko Schuster; Annika Nelde

Jonas S Heitmann; Melanie Märklin; Felicia M Truckenmüller; Clemens Hinterleitner; Daniela Dörfel; Michael Haap; Hans-Georg Kopp; Stefan Wirths; Martin R Müller

Journal of Leukocyte Biology. 108:1851-1857

Ho, Jenny N H G; Schmidt, Dominik; Lowinus, Theresa; Ryoo, Jeongmin; Dopfer, Elaine-Pashupati; Gonzalo Núñez, Nicolás; Costa-Pereira, Sara; Toffalori, Cristina; Punta, Marco; Fetsch, Viktor; Wertheimer, Tobias; Rittmann, Marie-Claire; Braun, Lukas M; Follo, Marie; Briere, Christelle; Vinnakota, Janaki Manoja; Langenbach, Marlene; Koppers, Felicitas; Shoumariyeh, Khalid; Engel, Helena; Rückert, Tamina; Märklin, Melanie; Holzmayer, Samuel; Illert, Anna L; Magon, Federica; Andrieux, Geoffroy; Duquesne, Sandra; Pfeifer, Dietmar; Staniek, Julian; Rizzi, Marta; et al

Zekri L; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Hagelstein I; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Märklin M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Klimovich B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Christie M; School of Medical Sciences, University of Sydney, 2050 NSW, Australia.; Lindner C; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Kämereit S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Prakash N; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Müller S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Stotz S; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; Maurer A; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; Greve C; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Schmied B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Atar D; Childrens University Hospital, University Hospital Tübingen, 72076 Tübingen, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Jung G; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Goyal A; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bauer J; Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Hey J; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Israeli Helmholtz Research School in Cancer Biology, Heidelberg, Germany.; German Center for Lung Research, (DZL) partner site Heidelberg, Heidelberg, Germany.; Papageorgiou DN; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg University, Medical Faculty, Heidelberg, Germany.; Stepanova E; Translational Control and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Daskalakis M; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern, University Hospital, University of Bern, Bern, Switzerland.; Scheid J; Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Dubbelaar M; Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Klimovich B; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Schwarz D; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Märklin M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Roerden M; Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Lin YY; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ma T; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Mücke O; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Loayza-Puch F; Translational Control and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Krijgsveld J; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg University, Medical Faculty, Heidelberg, Germany.; Walz JS; Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Plass C; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.plass@dkfz.de.; German Center for Lung Research, (DZL) partner site Heidelberg, Heidelberg, Germany. c.plass@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. c.plass@dkfz.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Holzmayer SJ; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK); Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Liebel K; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK); Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Hagelstein I; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK); Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK); Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Märklin M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK); Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Stefańczyk SA; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Hagelstein I; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Lutz MS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Müller S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Holzmayer SJ; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Jarjour G; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Zekri L; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany.; Märklin M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany. Melanie.Maerklin@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Tübingen, Germany. Melanie.Maerklin@med.uni-tuebingen.de.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE